Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01670539 · ClinicalTrials.gov registry record · NA

Home Telemonitoring for Patients With Lung Cancer

A NA study, sponsored by West Virginia University.

Completed
Registry status
NA
Development phase
47
Enrollment target

NCT01670539: Completed NA study, sponsored by West Virginia University.

NCT01670539 is a NA study that has completed, run by West Virginia University. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01670539, a NA study, has completed, sponsored by West Virginia University.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target

Study Summary

The purpose of this study is to learn more about using a home machine "Telemonitor" to find problems people with lung cancer may have after being discharged from the hospital and help them manage problems by contacting their healthcare provider.The study hypothesis is that patients with lung CA using short-term (14 days)home telemonitors, educated/coached by nurses on telemonitor data risks/implications for the first two weeks after hospital discharge, will be able to self-report their signs/ symptoms to the clinician resulting in decreased use of costly health care resources over 60 days.

Primary Outcome

Changes in temperature measured by telemonitor daily over 14 days after hospital discharge

Interventions

  • DEVICE HomMed Telemonitor

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2011-04
Est. Completion 2013-06
Phase NA
West Virginia University

122 total trials

What the finished NCT01670539 record still lists

NCT01670539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which HomMed Telemonitor is the first listed.

NCT01670539 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01670539 about?

NCT01670539 is a clinical study titled "Home Telemonitoring for Patients With Lung Cancer". The purpose of this study is to learn more about using a home machine "Telemonitor" to find problems people with lung cancer may have after being discharged from the hospital and help them manage problems by contacting their healthcare provider.The study hypothesis is that patients with lung CA usin...

What is the current status of trial NCT01670539?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2011-04. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01670539?

The interventions under investigation include: HomMed Telemonitor (DEVICE).

Who is sponsoring clinical trial NCT01670539?

This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01670539's enrollment target sits among peer trials

47 1400th of 2000 higher than 599 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01670539, the US trial registry maintained by the National Library of Medicine. NCT01670539 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.